Reklama
twitter
youtube
facebook
instagram
linkedin
Reklama
Reklama

Krka, tovarna zdravil, d.d., Novo mesto: 2023 Group performance estimate, establishment of joint venture in India (2024-01-25)

|
selectedselectedselected
Reklama
Aa
Udostępnij
facebook
twitter
linkedin
wykop

UNI-EN 4:2023 Krka Group Performance Estimate and Notification on Establishment of Joint Venture in India

Firma: KRKA, TOVARNA ZDRAVIL D.D.
Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. 2023 Krka Group Performance Estimate.pdf2023 Krka Group Performance Estimate
  2. Notification on establishment of a joint venture in India.pdfNotification on establishment of a joint venture in India

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 4 / 2024
Date of issue: 2024-01-25
Short name of the issuer
KRKA
Subject
2023 Krka Group Performance Estimate and Notification on Establishment of Joint Venture in India
Official market - legal basis
art. 17. 1 MAR.
Unofficial market - legal basis
Contents of the report:
Based on the provisions of Article 26 of the Ljubljana Stock Exchange Rules, Article 158 of the Market in Financial Instruments Act, and Article 17 of Regulation (EU) No 596/2014, Krka, d. d., Novo mesto (hereinafter: Krka) releases the 2023 unaudited performance estimates for the Krka Group and notification on establishment of joint venture in India.

The press releases with 2023 Krka Group performance estimate and notification on establishment of joint venture in India are attached.

This announcement will be published on the company’s website (www.krka.biz) starting from 25 January 2024, for a minimum period of 5 years.
Annexes
File Description
2023 Krka Group Performance Estimate.pdf
2023 Krka Group Performance Estimate.pdf
2023 Krka Group Performance Estimate
Notification on establishment of a joint venture in India.pdf
Notification on establishment of a joint venture in India.pdf
Notification on establishment of a joint venture in India

KRKA, TOVARNA ZDRAVIL D.D.
(fullname of the issuer)
KRKA Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
8501 Nove Mesto
(post code) (city)
Smarjeska 6
(street) (number)
+386 7 331 21 11 +386 7 332 15 37
(phone number) (fax)
(e-mail) (web site)
nie dotyczy
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2024-01-25 Jože Colarič President of the management board and CEO

Cena akcji Krka

Cena akcji Krka w momencie publikacji komunikatu to 508.02 PLN. Sprawdź ile kosztuje akcja Krka aktualnie.

W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Krka.

Jesteś dziennikarzem i szukasz pracy? Napisz do nas

Masz lekkie pióro? Interesujesz się gospodarką i finansami? Możliwe, że szukamy właśnie Ciebie.

Zgłoś swoją kandydaturę

Reklama